Tibetan Medicine for cancer: An Overview and Review of Case Studies

An original article titled as “Tibetan Medicine for cancer: An Overview and Review of Case Studies” was published in the journal of Integrative Cancer Therapies by Sage Publication. It's online publication was carried out on September 10 2014, DOI: 10.1177/1534735414549624 followed by the hard copy publication of article in the issue of Nov. 2014, VOLUME 13, NUMBER 6, 502-512. The work was the result of the collaborative effort initiated between Dr. Susan of Virginia University, team members of Emory University and Men Tsee Khang in the year 2011. The abstract of the article is incorporated below to present a brief synopsis of the paper.
Kindly visit this link: Integrative Cancer Therapies for detailed information.
Tibetan Medicine for Cancer: An Overview and Review of Case Studies

Susan Bauer-Wu, PhD, RN, FAAN1, Tenzin Lhundup (Kachupa)2,*, Tawni Tidwell, MA3,4, Tenzin Lhadon (Menrampa)2,*, Chikako Ozawa-de Silva, PhD3, Jamyang Dolma (Menrampa)5,*, Pema Dorjee (Menrampa)2,6,*,Dorjee Rapten Neshar (Menrampa)7,*, Rigzin Sangmo, (Menrampa)2,*, and Tenzin Yeshi (Kachupa)2,*
____________________________________________________________________
* Kachupa is similar to Bachelor of Science in Medicine (BS), and Menrampa is similar to Doctor of Medicine (MD)

1 University of Virginia, Charlottesville, VA, USA
2 Men-Tsee-Khang, Tibetan Medical & Astro Institute, Dharamsala, India
3 Emory University, Atlanta, GA, USA
4 Tibetan Medical College, Qinghai University, Xining, Qinghai, P.R.C
5 Men-Tsee-Khang, Salugara Branch Clinic, Salugara, India
6 Men-Tsee-Khang retired physician
7 Men-Tsee-Khang, Bengaluru Branch Clinic, Tibetan Medical Centre, Bangalore, India

Corresponding Author: Susan Bauer-Wu, University of Virginia, 225 Jeanette Lancaster Way, Charlottesville, VA 22903, USA. Email: bauer-wu@virginia.edu

Abstract

Introduction: Tibetan medicine (TM) is a whole systems medical approach that has had growing interest in the West. However, minimal research, particularly with cancer, has been conducted. The purpose of this article is to provide an overview of TM and describe a clinical case review study to obtain preliminary evidence of TM’s safety and effect on patients treated for cancer or hematologic disorders. Methods: A retrospective case review was conducted in India and cases met the following inclusion criteria: (a) confirmed diagnosis of cancer or hematologic disorder by standard Western biomedical diagnostic tests, (b) either treated exclusively with TM or received insufficient Western treatment followed by TM and (c) were in remission or had stable disease at least 2 years after start of TM. Results: Three cases were identified, 1 solid tumor and 2 hematologic diseases: Case 1—poorly to moderately differentiated adenocarcinoma of the stomach, positive lymph nodes and mucosal infiltration, with clear scans and excellent quality of life 29 months later ; Case 2—chronic myelogenous leukemia with normalization of hematologic labs within 3 months of starting TM and stable 4 years later; and Case 3—red cell aplasia improved significantly and reversed dependence on blood transfusions with TM. None of the cases experienced demonstrable adverse effects from TM. Conclusions: This limited case review found TM to be safe and have positive effects on quality of life and disease regression and remission in patients with cancer and blood disorders. Further exploration and investigation using rigorous methods is warranted.

Key words
Tibetan medicine, whole systems, case study, CAM, integrative oncology